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Several cytoplasmic corniﬁed envelope precursors have been described. Nevertheless, the mechanism whereby
these proteins are positioned at the site of crosslink formation is not known. In this study, we examine the
intracellular distribution of the corniﬁed envelope precursor S100A11 (S100C) and the effects of the physiologic
differentiating agent calcium on this distribution. S100A11 is localized in the cytoplasm of resting cultured human
keratinocytes. Treatment with calcium causes S100A11 to relocate to the cell periphery. Immunoprecipitation
studies reveal that S100A11 associates with microtubules, and inhibitor studies indicate that functional micro-
tubules are required for S100A11 peripheral redistribution. Parallel studies indicate that S100A11 is not present
in the Golgi or endoplasmic reticulum (ER), suggesting that S100A11 is not moved to the cell periphery via
the classical Golgi/ER export pathway. Further evidence that the Golgi/ER is not involved is provided by the
observation that the Golgi/ER disruptor brefeldin A does not alter movement. These results suggest that
redistribution along microtubules is a mechanism whereby S100A11 is positioned at the cell periphery in
preparation for transglutaminase-dependent crosslinking. Staining of epidermal tissue sections from uninvolved
and psoriatic epidermis reveals strong staining at the cell periphery in the majority of suprabasal cells, conﬁrming
a peripheral distribution of S100A11 in vivo.
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S100 proteins are small, multifunctional, calcium-regulated
proteins (Donato, 1986; Heizmann, 1986; Schafer and
Heizmann, 1996) encoded by genes that are clustered in
the epidermal differentiation complex on chromosome 1q21
(Moog-Lutz et al, 1995; Mischke et al, 1996). These EF-
hand-containing proteins undergo a conformational change
in response to increased intracellular calcium (Donato,
1999). This conformation change exposes domains that
permit S100 proteins to interact with target proteins to
modify target protein function. S100A11 is a member of
this family that is localized in the cytoplasm in resting
keratinocytes. Our previous studies demonstrate that
S100A11 serves as a transglutaminase substrate and a
cornified envelope precursor (Robinson et al, 1997; Robin-
son and Eckert, 1998; Ruse et al, 2001).
The mechanism whereby cornified envelope precursors
are positioned at the cell periphery is not well understood.
Several envelope precursors, including loricrin and profilag-
grin, are deposited at the site of envelope formation via
vesicle delivery mechanisms (Kalinin et al, 2002; Steven
et al, 1990). This occurs late in the envelope assembly
process. Nevertheless, this vesicle-based mechanism
cannot explain the positioning of soluble cytoplasmic
envelope precursors at the cell periphery that occurs early
in envelope assembly. It has been proposed that soluble
proteins such as involucrin may move to the plasma
membrane via a diffusion-based mechanism (Eckert et al,
1993; Kalinin et al, 2002); however, little in situ evidence
is available to support this claim. In this report, we have
selected S100A11 as a model protein to study the
mechanism of soluble cornified envelope precursor move-
ment to the cell periphery. Our results suggest that calcium
promotes mobilization of S100A11 to the cell periphery and
that the S100A11 travels along the microtubule network.
Results
S100A11 antibody speciﬁcity We first assessed the
specificity of the S100A11 antibody. Normal human kera-
tinocytes were fixed and stained with anti-S100A11. As
shown in Fig 1A, the antibody detected a diffuse pattern of
cytoplasmic staining (anti-S100A11). In contrast, the signal
is competed by incubation of the antibody with rhS100A11
(anti-S100A11þ rhS100A11). In addition, no signal is
observed when a preimmune antibody is used or the
primary antibody is omitted (not shown). Figure 1B shows
that anti-S100A11 detects rhS100A11 (A11), but not the
related S100 protein, rhS100A10 (A10), and Fig 1C shows
that adsorption of anti-S100A11 with rhS100A11 eliminates
Abbreviations: ER, endoplasmic reticulum; HRP, horse-
radish peroxidase; PBS, phosphate-buffered saline.
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anti-S100A11 binding to total extracts prepared from
keratinocytes.
Intracellular S100A11 localization To identify the intracel-
lular location of S100A11 in cultured keratinocytes, sub-
confluent cultures, growing in 0.09 mM calcium, were
treated with medium containing 0.09 or 0.3 mM calcium for
1 h. The cells were then fixed and costained with anti-
S100A11 (red) and anti-annexin I (green) (Fig 2A). The
circles, in representative cells, indicate the perimeter of the
nucleus. In cells maintained in 0.09 mM calcium, S100A11
distributes throughout the cytoplasm, including the region
adjacent the nucleus. Annexin I is a known partner of
S100A11 (Seemann et al, 1996). As expected, annexin I
distributes in similar locations. In cells treated with 0.3 mM
calcium, S100A11 and annexin I both redistribute toward
the cell periphery (arrows). Overlay of the red and green
images identifies significant signal overlap (yellow), sug-
gesting that S100A11 and annexin I partially colocalize.
Because the reduction in perinuclear S100A11 and annexin
I level observed in calcium-treated cells could be caused by
a reduction in protein level, we monitored S100A11 and
annexin I protein levels. As shown in Fig 2B,C, neither
S100A11 nor annexin I level is altered by calcium treatment.
Calcium-dependent S100A11 redistribution requires
intact tubulin ﬁlaments Tubulin filaments have been
reported to mediate S100A11 movement in human glio-
blastoma cells (Davey et al, 2000). We therefore assessed
whether this was the case in human keratinocytes. Cells
were treated for 2 h with or without 1 mM vincristine, an
agent that disrupts and collapses microtubules. The cells
were then treated with 0.09 or 0.3 mM calcium for 1 h, fixed,
and stained with a cocktail containing anti-S100A11 and
anti-b-tubulin (Fig 3). In the absence of vincristine, treatment
with 0.3 mM calcium results in a clearing of S100A11 (green)
away from the nucleus toward the cell periphery (arrows).
In contrast, treatment with vincristine causes microtubule
collapse with formation of perinuclear aggregates (red).
Figure 1
S100A11 antibody specificity. (A) Normal human epidermal keratino-
cytes, grown on coverslips, were fixed and incubated with anti-
S100A11 (1:100, 114 mg/mL) without or with adsorption with 340 mg/mL
rhS100A11. The slides were then incubated with the appropriate
secondary antibody. The fluorescent signal was detected using
confocal microscopy. (B) Anti-S100A11 does not detect other S100
proteins. Recombinant human S100A10 and S100A11 (5 mg/lane) were
electrophoresed and blotted with anti-S100A11. Migration of the
S100A11 monomer (M) and dimer (D) are indicated. (C) Detection of
S100A11 in keratinocyte total extracts is blocked by incubation with
rhS100A11. Total keratinocyte cell extract was prepared, electrophor-
esed and blotted with anti-S100A11 (1:1000, 11.4 mg/mL) without (–) or
with (þ ) absorption with 34.2 mg per mL rhS100A11. The blot was then
incubated with anti-S100A11 and visualized using the appropriate
secondary antibody. M, migration of the S100A11 monomer.
Figure2
S100A11 colocalizes with annexin I and relocates to the cell
periphery upon calcium stimulation. (A) Human keratinocytes were
cultured on coverslips and treated with low (0.09 mM) or high (0.3 mM)
calcium-containing medium for 1 h at 371C. The cells were then fixed,
permeabilized, and stained with anti-S100A11 (red) or anti-annexin I
(green). Circles, the perimeter of the nucleus of selected cells. Arrows,
the direction of redistribution following calcium treatment. The overlay
images represent the combined S100A11 and annexin I lineage. Yellow
indicates colocalization of S100A11 and annexin I. Bars, 10 mm. (B,C)
Calcium treatment does not alter S100A11 or annexin I level. Human
keratinocytes were treated as above, and cell extracts were prepared.
An equivalent amount of each sample, based on protein, was electro-
phoresed on a denaturing 12% polyacrylamide gel. The fractionated
proteins were then immunoblotted with mouse anti-b-actin, anti-
annexin I, or rabbit anti-S100A11. The blots were then washed and
incubated with the appropriate secondary detection reagent, and
antibody binding was visualized using chemiluminescent detection
methods. The numbers indicate molecular weight in kilodaltons.
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S100A11 codistributes to this location (þVincristine,
arrows) and cannot be mobilized to the cell periphery by
0.3 mM calcium. These results suggest that S100A11
interacts with tubulin filaments and that perturbing these
filaments influences S100A11 localization.
To assess the specificity of S100A11 interaction with
b-tubulin, we assayed for association of a related S100
protein, S100A10, with microtubules. As shown in Fig 4,
S100A10 is present in the cytoplasm of cells maintained in
medium containing 0.09 mM calcium. Shifting to 0.3 mM
calcium does not result in relocation of S100A10 to the cell
periphery. In addition, the overlay image indicates that
S100A10 does not colocalize with b-tubulin.
To provide direct evidence for S100A11 interaction with
b-tubulin, total keratinocyte extracts were precipitated with
anti-b-tubulin and blotted with anti-S100A11 or rabbit
nonimmune serum. As shown in Fig 5A, anti-b-tubulin, but
not nonimmune serum, precipitates S100A11. The precipi-
tated S100A11 migrates as a monomer and as additional
high-molecular-weight forms (). Except for one band
migrating at nearly 82 kDa, the monomer and higher
molecular weight forms migrate with the corresponding
S100A11 forms present in total extract. The inverse experi-
ment is shown in Fig 5B. This experiment shows that
precipitation of total extracts with anti-S100A11 results in
precipitation of b-tubulin.
Because various forms of S100A11 (i.e., monomers,
dimers, and high-molecular-weight multimers) exist within
the cell and interact with b-tubulin (Fig 5A), we examined
whether these S100A11 forms are located within specific
regions of the cell. Subconfluent keratinocytes were frac-
tioned into a soluble cytosolic fraction, a detergent-soluble
membrane fraction, and a detergent-insoluble cytoskeletal
fraction. The individual fractions were normalized by
volume, electrophoresed, and transferred to nitrocellulose.
The blots were then incubated with anti-S100A11 or rabbit
nonimmune serum. As show in Fig 5C, S100A11 monomers
were detected in the cytosolic (supernatant, S) fraction. In
contrast, high-molecular-weight S100A11-immunoreactive
material is observed in the cytoskeletal (pellet, p) fraction.
No S100A11 immunoreactivity is observed in the solubilized
membrane fraction (M).
S100A11 does not localize in the Golgi or endoplasmic
reticulum (ER) The above results suggest that S100A11
redistributes independently of the Golgi/ER export pathway.
To confirm that S100A11 does not localize within the Golgi/
ER, we stained keratinocytes with anti-S100A11 and
costained with Golgi and ER markers. Figure 6A compares
the staining pattern of GM130 (red), a Golgi matrix protein,
and S100A11 (green) in cells maintained in a low concen-
tration (0.09 mM) of calcium. As expected, GM130 dis-
tributes in a tubular pattern that is particularly intense
surrounding the nucleus. In contrast, S100A11 is predomi-
nantly localized in the cytoplasm. The overlay indicates that
there is no codistribution. Treatment with calcium (0.3 mM)
causes S100A11 to move toward the cell periphery (arrows),
but GM130 remains as a ring surrounding the nucleus. This
Figure 3
S100A11 redistribution to the cell periphery requires intact tubulin
filaments. Keratinocytes, growing on coverslips, were treated for 2 h at
37C in the absence or presence of 1 mM vincristine, a microtubule
destabilizer. The cells were then maintained for 1 h in medium
containing 0.09 or 0.3 mM calcium, fixed, permeabilized, and costained
with anti-S100A11 (green) and anti-b-tubulin (red). The images were
obtained by confocal microscopy. The overlay image indicates the
combination of the S100A11 and b-tubulin images. Colocalization is
identified by yellow color. Circles, the perimeter of the nuclei; arrows,
indicate the direction of S100A11 redistribution. No arrows are shown
in the b-tubulin panel, because b-tubulin does not move in response to
calcium treatment. In the vincristine-treated images, the arrows
indicate the direction of tubulin retreat from the cell periphery. Bars,
10 mm.
Figure4
S100A10 does not colocalize with tubulin filaments. Human
keratinocytes were cultured on coverslips and treated with low (0.09
mM) or high (0.3 mM) calcium-containing medium for 1 h at 371C. The
cells were then fixed, permeabilized, and immunostained with anti-
S100A10 (green) or anti-b-tubulin (red). The overlay panels indicate the
combined images. Bars, 10 mm.
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is particularly evident in the overlay (Fig 6A) where the
S100A11-associated green stain is in the cell periphery and
the GM130-associated red stain decorates the nuclear
perimeter.
Figure 6B compares the distribution of the ER marker BiP
and S100A11. BiP staining (red) is present in a punctate
pattern surrounding the nucleus. In comparison, S100A11 is
present throughout the cytoplasm. Treatment with calcium
causes S100A11, but not BiP, to clear from the perinuclear
region (arrows). This is best visualized by comparing the inter-
mingling of the BiP-positive structures and the S100A11
staining in the overlay of cells maintained in 0.09 mM
calcium to the distinct separation of the BiP and S100A11
staining in the overlay of cells treated with 0.3 mM calcium.
Brefeldin A disruption of the Golgi complex does not
alter S100A11 distribution Brefeldin A is a fungal meta-
bolite that causes disintegration of the Golgi complex
and interferes with classical protein secretion by block-
ing vesicle budding in the secretory pathway. Brefeldin
A-treated Golgi form elongated tubules along the cell
periphery (Sciaky et al, 1997) that eventually fuse with the
ER, blocking retrograde transport and protein secretion
(Pelham, 2001). In the absence of Brefeldin A treatment, the
Golgi complex, as visualized using anti-GM130 (red), forms
a loosely oriented array around the nucleus (Fig 7A).
Disruption of the Golgi apparatus, as evidenced by the
redistribution of GM130 staining, occurs in keratinocytes
after 30 min of brefeldin A treatment (Fig 7A). Figure 7B
(– brefeldin A) shows the redistribution of S100A11 that
occurs following calcium treatment (left panels, arrows). The
right panels show that brefeldin A treatment does not
impede the calcium-dependent redistribution of S100A11 to
the cell periphery (arrows). These results suggest that
S100A11 distribution and redistribution is not mediated by
the Golgi/ER system.
S100A11 in epidermal keratinocytes in vivo Taken
together, the above results suggest that S100A11 redis-
tributes to the cell periphery in calcium-treated keratino-
cytes and predicts that S100A11 may associate with
peripheral structures in keratinocytes in vivo. To examine
the in vivo distribution of S100A11, sections of normal and
psoriatic epidermis were stained with anti-S100A11. Figure
8 displays the peripheral staining of S100A11 that is
apparent in suprabasal epidermal keratinocytes. This peri-
pheral staining is observed in both normal and psoriatic
epidermis (arrows). In a small percentage of cells there is
intense nuclear staining (circles).
Figure6
S100A11 does not localize in the ER or Golgi. Keratinocytes, growing
on coverslips, were treated for 1 h in medium containing 0.09 or 0.3 mM
calcium. The cells were then fixed, permeabilized, and immunostained
with a cocktail containing anti-S100A11 (green) and either anti-GM130
(A, red) or anti-BiP (B, red). The images were then collected by confocal
microscopy. The overlay image shows the combined red and green
signals—no yellow signal is detected, indicating a lack of colocalization
of S100A11 and GM130 or BiP. Bars, 10 mm.
Figure 5
Coprecipitation of S100A11 and b-tubulin. (A) Extracts from human
keratinocytes grown in 0.09 mM calcium-containing medium were
prepared in lysis buffer and then precipitated with anti-b-tubulin or
nonimmune serum. The precipitated samples were then electrophor-
esed and blotted with anti-S100A11. Total extract (TE) was electro-
phoresed in a parallel lane. Migration of the S100A11 monomer, and
higher-molecular-weight immunoreactive forms () are indicated. (B)
Extracts, prepared as above, were precipitated using anti-S100A11 or
nonimmune serum, electrophoresed, and blotted with anti-b-tubulin.
TE was electrophoresed in a parallel lane. Antibody binding was
visualized using the appropriate secondary antibody and chemilumi-
nescent detection reagent. (C) Cell supernatant, membrane, and
particulate fractions were prepared as outlined under Materials and
Methods. Equal cell equivalents of each fraction were electrophoresed
and immunoblotted with anti-S100A11. The S100A11 monomer is
indicated, as is the migration of the larger multimers (). No signal was
observed when nonimmune serum was substituted for anti-S100A11.
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As noted above, nuclear localization was not observed in
subconfluent cultured keratinocytes. One possibility is that
the extent of confluence may promote nuclear appearance
of S100A11. To evaluate this, we maintained postconfluent
cultures for several days and then compared the effects
of calcium treatment on S100A11 distribution. As shown in
Fig 9A, in confluent cultures maintained in 0.09 mM calcium,
S100A11 is distributed in the cytoplasm with no nuclear
staining. The cytoplasmic distribution is particularly evident
in the orthogonal image (yellow arrow). The confocal series,
shown at the right, indicates the absence of nuclear staining
in successive optical sections (1.8 mm is near the substrate/
cell interface, whereas the 12.23-mm section is near the
culture surface). Figure 9B shows that after a 1-h treatment
in 0.3 mM calcium-containing medium, S100A11 has
moved to the cell periphery as indicated by the white
arrows (top view) and the yellow arrow (orthogonal view).
Again, no S100A11 is detected within the nucleus. In
addition, S100A11 redistribution after treatment for 1 h with
1.2 mM calcium-containing medium was not significantly
different from the S100A11 redistribution observed after
0.3 mM calcium treatment (not shown).
Nuclear staining of Langerhans cells An alternate pos-
sibility is that the nuclear staining (Fig 8) identifies another
epidermal cell type. The epidermis harbors a limited
population of dendritic antigen-presenting cells—the
Langerhans cells (Nestle and Nickoloff, 1995). To assess
whether Langerhans cells express nuclear S100A11, epi-
dermal sections, prepared from normal and psoriatic tissue,
were stained with anti-S100A11 and anti-CD1a. CD1a is
a cytoplasmic Langerhans cell marker (Teunissen, 1992).
Figure 10A shows the peripheral green anti-S100A11
staining in keratinocytes (arrows). Staining of normal
epidermis with anti-CD1a specifies a small number of
Langerhans cells (e.g., circle). More CD1a-positive cells are
present in this section of psoriatic epidermis. It is interesting
that many of the CD1a-positive cells also display nuclear
anti-S100A11 immunoreactivity (e.g., circle). Figure 10B
shows an enlargement of the boxed area from Fig 10A. This
S100A11/CD1a-positive cell shows the cytosolic staining
characteristic of CD1a (red) and the nuclear staining of
S100A11 (green). These results suggest that the S100A11
nuclear epidermal staining is due to S100A11 presence in
the nucleus of Langerhans cells.
Figure 7
Redistribution of S100A11 does not require an intact Golgi
complex. (A) Keratinocytes, grown on coverslips, were fixed, permea-
bilized, and treated for 30 min in the presence or absence of 5 mg per
mL brefeldin A, an agent that disrupts the Golgi apparatus. The cells
were then collected, fixed, and incubated with anti-GM130 (red) and
stained with Hoechst nuclear stain (blue). (B) Cells were treated without
or with brefeldin A for 30 min and then further treated with 0.09 or 0.3
mM calcium for 1 h at 371C followed by immunostaining with anti-
S100A11 (green). Arrows, redistribution of S100A11 in response to
calcium treatment. Circles, the perimeter of the nuclei. Bars, 10 mm.
Figure8
S100A11 in epidermis. Biopsies were excised from normal and
psoriatic-involved epidermis. The specimens were fixed, processed,
and stained with rabbit anti-human S100A11 (diluted 1:100). (A) Normal
epidermis stained with anti-S100A11. The right panel is a higher
magnification image of the left panel. (B) Involved psoriatic epidermis
stained with anti-S100A11. The right panel is a higher magnification
image of the left panel. S100A11 is distributed in the cytoplasm of cells
in the basal and spinous layers. The arrows indicate peripheral
S100A11 localization in the granular layer. Some nuclear staining is
observed in selected upper granular layer cells (circles). Parallel
sections stained with preimmune serum showed no reactivity (not
shown).
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S100A11 peripheral distribution is enhanced by 12-
O-tetradecanoylphorbol-13-acetate and thapsigargin
The above studies show that treatment of keratinocytes
with calcium promotes S100A11 redistribution to the cell
periphery. To determine whether other keratinocyte regula-
tory agents (Efimova et al, 1998; Balasubramanian et al,
2000) produce a similar response, cells were treated with
12-O-tetradecanoylphorbol-13-acetate or thapsigargin for
60 min. Figure 11 shows that both of these agents promote
peripheral redistribution of S100A11 immunoreactivity.
Discussion
Calcium- and microtubule-dependent redistribution of
S100A11 S100 proteins comprise a family of structurally
related proteins that serve as markers of cell proliferation,
death, and differentiation (Donato, 1999; Heizmann and
Cox, 1998). Subcellular distribution and stimulus-depen-
dent redistribution of S100 protein complexes are important
factors that influence S100 protein activity and function.
In keratinocytes, S100 proteins are transglutaminase sub-
strates and cornified envelope precursors (Robinson et al,
1997; Robinson and Eckert, 1998; Ruse et al, 2001). Thus,
S100 proteins serve as models for studying the mechanism
whereby soluble proteins are incorporated into the cornified
envelope. In this study, we examine the distribution of
S100A11 in keratinocytes and its redistribution following
treatment with differentiating agent.
In glioblastoma cells, S100 proteins undergo calcium-
dependent translocation from the cytosol to plasma
membrane-associated vesicles (Davey et al, 2000). Our
studies show that elevating extracellular calcium results in a
net redistribution of S100A11 from the cytoplasm toward the
cell periphery in keratinocytes. This redistribution is inhibited
by vincristine, a microtubule disassembly agent. Vincristine
promotes tubule collapse and the resulting formation of a
perinuclear tubulin ring. S100A11 redistributes to this ring,
presumably carried to this location attached to tubulin.
Immunoprecipitation experiments confirm an S100A11 inter-
action with tubulin. In contrast, S100A11 does not localize
with Golgi or ER markers, suggesting that S100A11 does
not distribute in these structures. In addition, brefeldin A,
Figure 9
S10011 distribution and redistribution in
confluent keratinocytes. Keratinocytes
were plated on coverslips and permitted to
become confluent. (A) Keratinocytes, main-
tained at confluence for several days in
medium containing 0.09 mM calcium, were
harvested, fixed, stained, and incubated with
anti-S100A11 (diluted 1:100). The small frames
indicate serial images beginning near the cell/
substrate interface (1.85 mm) and proceeding
upward to the cell surface (12.23 mm). The
large image includes orthogonal sections.
Yellow arrow, S100A11 staining in the cyto-
plasm. (B) Cells, maintained at confluence for
several days in medium containing 0.09 mM
calcium, were treated with 0.3 mM calcium for
1 h at 371C. The cells were harvested, fixed,
and incubated with anti-S100A11 (diluted
1:100). The small frames indicate serial images
beginning near the cell/substrate interface
(1.86 mm) and proceeding upward to the cell
surface (12.27 mm). Yellow arrow, peripheral
S100A11 staining on the orthogonal section.
White oval, indicates the extent of the nucleus.
White arrow, also indicates the peripheral
S100A11 staining in the surface image.
Figure 10
Nuclear staining of S100A11 in Langerhans cells. (A) Normal and
psoriatic epidermal sections were costained with 1:100 diluted rabbit
anti-human S100A11 (green) and 1:100 diluted mouse anti-CD1a (red).
Sections stained in the absence of primary antibody showed no
staining (not shown). Arrows, peripheral S100A11 staining in keratino-
cytes; circles, a representative CD1a-positive cell; line, traces the
dermal/epidermal junction. (B) This panel shows an enlarged view of
the section of A enclosed by the rectangle. The Langerhans cell
dendrites are indicated by the projections.
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which blocks the classical ER–Golgi secretory pathway, does
not influence calcium-dependent S100A11 redistribution or
localization, suggesting that the classical secretory pathway
is not involved in S100A11 redistribution. Our results in
keratinocytes agree with another published report wherein
Heizmann and colleagues observed Brefeldin A-independent
redistribution of S100A11 in glioblastoma cells (Davey et al,
2000). These results suggest that S100A11 associates with
microtubules and that microtubules mediate movement of
S100A11 to the cell periphery.
A similar dependence on microtubules has been noted
for other S100 proteins. Rammes et al (1997) noted that
S100A8 and S100A9 are secreted independently of the
classic Golgi/ER pathway and Roth and coworkers (1993)
demonstrated a microtubule requirement for S100A8/
S100A9 redistribution in myelomonocytic cells. Our studies
further suggest that S100A11 remains associated with
microtubules following brefeldin A-associated collapse.
This is consistent with the observations of Donato and
colleagues who showed that S100B remains associated
with microtubules following treatment with agents that alter
microtubule structure in U251 glial cells (Sorci et al, 1998).
Taken together, these results suggest that S100 proteins
migrate on microtubules. The absence of movement via a
Golgi/ER mechanism is consistent with the observation that
S100 proteins lack the signal sequences (Schafer and
Heizmann, 1996) required for secretion. This Golgi/ER-
independent mechanism has been noted for a limited set of
proteins and was first described for cytokine secretion by
Muesch et al (1990).
Heizmann and colleagues described S100A11 move-
ment to the cell periphery coupled with formation of
S100A11-enriched cell surface vesicles in glioblastoma
cells (Davey et al, 2000). In contrast, in human keratino-
cytes, we observe distribution of S100A11 to the cell
periphery without vesicle formation. This could result from
the use of a different stimulus, as Heizmann and coworkers
stimulated with thapsigargin (Davey et al, 2000), an agent
that promotes the release of intracellular calcium stores via
depletion of IP3-senstive ER stores, and we stimulated with
increased extracellular calcium, a physiologic stimulus of
keratinocyte differentiation (Rice and Green, 1979; Boyce
and Ham, 1983; Hennings et al, 1989; Eckert et al, 1997).
Nevertheless, additional studies in keratinocytes (Fig 11)
reveal that thapsigargin and 12-O-tetradecanoylphorbol-
13-acetate produce a redistribution to the cell periphery that
is essentially identical to that observed with calcium. This
suggests that treatment with thapsigargin causes S100A11
to move via different mechanisms and to different locations
in the two cell types. It also implies that S100A11 function
may differ in the two cell types.
S100A11 colocalizes with annexin I Gerke and collea-
gues have shown that the calcium/phospholipid-binding
protein annexin I forms a complex with S100A11 (Seemann
et al, 1996). In vitro, this binding inhibits the protein kinase
C-associated phosphorylation of annexin I (Naka et al,
1994), suggesting that S100A11 may influence protein
kinase C-dependent signal transduction. We monitored
S100A11 and annexin I distribution before and following
calcium treatment and found a strong colocalization of
S100A11 and annexin I and the redistribution of both
proteins to a peripheral location following calcium treat-
ment. We hypothesize that this movement is necessary to
position S100A11 and annexin I for transglutaminase-
dependent incorporation into the cornified envelope
(Robinson et al, 1997; Robinson and Eckert, 1998; Ruse
et al, 2001). Type I transglutaminase is a plasma membrane-
anchored enzyme in keratinocytes that catalyzes formation
of covalent isopeptide bonds and drives assembly of the
cornified envelope (Phillips et al, 1993; Rice et al, 1992). Our
Figure 11
Regulation of S100A11 distribution by other regulatory agents.
Keratinocytes, growing on coverslips, were treated for 1 h with 5 ng per
mL 12-O-tetradecanoylphorbol-13-acetate or 0.5 mM thapsigargin
(TGN). The cells were then fixed, permeabilized, and immunostained
with rabbit anti-human S100A11 (green). White arrows, redistribution of
S100A11 in response to treatment with differentiating agents, 12-O-
tetradecanoylphorbol-13-acetate or TGN. Circles, the perimeter of the
nuclei. Yellow arrows, the direction of S100A11 redistribution in the
orthogonal sections.
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results suggest that S100A11 and annexin I are delivered
from the cell cytosol to the cell periphery via a calcium- and
microtubule-dependent mechanism and that both S100A11
and annexin I are then crosslinked by type I transglutami-
nase, a calcium-activated enzyme, to form part of the
cornified envelope. Thus, the present studies suggest a
tubulin-associated mechanism whereby cornified envelope
precursors can be delivered to the site of crosslink
formation. This is consistent with the finding in Fig 5 that
the particulate fraction contains high-molecular-weight
anti-S100A11-immunoreactive bands. It is possible that
these bands represent partially crosslinked S100A11
(Robinson et al, 1997; Robinson and Eckert, 1998; Ruse
et al, 2001; Broome et al, 2003). It is intriguing that the
material is found in the particulate/cytoskeletal fraction and
that no S100A11 form was found associated with the
membranous fraction.
Distribution of S100A11 in epidermis Based on our
results using calcium-treated cultured keratinocytes, we
anticipated a peripheral distribution of S100A11 in differ-
entiated epidermis in vivo. Indeed, most cells in the
epidermal granular layer display a peripheral, membrane-
associated S100A11 localization in both normal and
psoriatic epidermis. Nevertheless, in addition to peripheral
staining, selected cells in the upper granular layer in normal
epidermis and throughout the epidermis in psoriasis
displayed nuclear staining. This is a particularly interesting
result, considering that Sakaguchi et al (2000) described
nuclear localization of phosphorylated S100A11 in confluent
immortalized human fibroblasts. This localization was
associated with elevation of p16 and p21 expression
(Sakaguchi et al, 2000). Elder and colleagues have also
shown that another S100 protein, S100A2, can shuttle
between the nucleus and cytoplasm in a stimulus-depen-
dent manner (Zhang et al, 2002). This finding suggests that
S100 proteins can move to the nuclear compartment in
some cell types. We could not detect nuclear S100A11
staining in these cultures, indicating that nuclear presence
is a rare event in cultured cells, at least in our culture
system. Because nuclear staining was restricted to a
few cells in epidermis, we suspected that the nuclear
stained cells may identify a nonkeratinocyte cell type.
Langerhans cells comprise a population of epidermal
antigen-presenting cells (Teunissen, 1992; Cumberbatch
et al, 2000). Langerhans cell precursors arise from CD34þ
monocytes in the bone marrow and circulate in the blood
before localizing in the skin. CD1a is not expressed in the
precursor cells, but is expressed in epidermal-localized
Langerhans cells (Banchereau et al, 2003; Reynolds et al,
1995; Vincent et al, 2002; Vincent et al, 2003). Our studies
suggest that S100A11 is present in the nucleus of CD1a-
positive Langerhans cells and that most, perhaps all, of the
S100A11 nuclear staining in epidermis is accounted for by
this population of cells. Additional studies, revealing an
absence of CD14 staining (Vincent et al, 2002; Vincent et al,
2003), confirm that these cells are not peripheral blood
monocytes or tissue macrophages (not shown). Langerhans
cells are known to express S100B (Boni et al, 1997);
however, expression of other S100 proteins has not been
assessed. The present studies suggest that Langerhans
cells also express S100A11. This may not be surprising,
because S100A11 and S100B are known to colocalize in
U373 astrocytoma cells and S100B and S100A11 form
calcium- and zinc-dependent heterocomplexes (Deloulme
et al, 2000). Thus, S100A11 and S100B may participate in
an at present unknown manner to regulate Langerhans cell
function.
In summary, based on the findings presented in this
article and those of previous reports (Robinson et al, 1997;
Robinson and Eckert, 1998; Ruse et al, 2001; Broome
et al, 2003), we speculate that S100A11 is present in
the cytoplasm of resting keratinocytes and, in response
to an increase in extracellular calcium, S100A11, along
with annexin I, moves to the plasma membrane where
it performs a presently unknown signaling function
before being incorporated, via a type I transglutaminase-
dependent mechanism, as a component of the keratinocyte
cornified envelope. These findings suggest a mechanism
of envelope precursor redistribution to plasma mem-
brane crosslinking sites that involves transport along
microtubules.
Materials and Methods
Keratinocyte cell culture Passage 3 human foreskin keratino-
cytes were maintained in keratinocyte serum free-medium, con-
taining 0.09 mM calcium, and supplemented with bovine pituitary
extract and epidermal growth factor (Efimova et al, 1998). In some
experiments, keratinocytes were transferred to medium containing
the differentiating agent, calcium, at 0.3 mM, for 1 h before harvest.
Antibody to recombinant human S100A11 Recombinant human
S100A11 protein was produced in Escherichia coli (BL21 DE3)
(Ruse et al, 2001). Bacteria were transformed with pET28a þ
S100A11, which encodes a polyhistidine–S100A11 fusion protein,
and His–S100A11 production was induced by addition of iso-
propylthio-b-D-galactoside. Following protein purification by chro-
matography on a His-Bind column (Novagen), the polyhistidine
track was removed by cleavage with thrombin, and the cleaved
S100A11 protein was removed from the polyhistidine fragment by
His-Bind column chromatography. Recombinant human S100A11
protein retains a three-amino-acid extension (Gly-Ser-His) at the
amino terminus. Rabbit anti-human S100A11 antibody was pre-
pared by immunizing rabbits with recombinant human S100A11
(1 mg of S100A11 per animal) three times over a period of 2 mo. At
4 mo, immune serum was collected from each rabbit, and the IgG
fraction was isolated by a salting-out procedure (50% ammonium
sulfate). We confirmed that the anti-S100A11 antibody reacts
specifically with the human S100A11 protein by immunoblot. The
optimal antibody concentration for immunofluorescence (1:1000)
and immunoblot (1:1000) was determined by serial dilution
(Broome et al, 2003).
Antibodies and reagents The antibodies include goat anti-human
annexin I (sc1922, Santa Cruz Biotechnology, Santa Cruz, CA),
mouse anti-human BiP (610978, BD Transduction Laboratories,
San Diego, CA), mouse anti-human GM130 (610822, BD Trans-
duction Laboratories), mouse anti-b-tubulin (T4026, Sigma, St.
Louis, MO), mouse anti-b-actin (A5441, Sigma), mouse anti-
CD1a (sc5265, Santa Cruz Biotechnology), mouse anti-CD14
(C7673, Sigma), Alexa Fluor 488-conjugated goat anti-rabbit
IgG (A11008, Molecular Probes, Eugene, OR), Alexa Fluor 488-
conjugated donkey anti-goat IgG (A11055, Molecular Probes),
Cy3-conjugated sheep anti-mouse IgG (C2181, Sigma), Cy3-
conjugated sheep anti-rabbit IgG (C2306, Sigma), horseradish
peroxidase (HRP)-conjugated donkey anti-rabbit IgG (NA934,
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Amersham Pharmacia Biotech, Piscataway, NJ), and biotin-labeled
goat anti-rabbit IgG (PK-6101, Vector Laboratories, Burlingame,
CA). Vincristine (V8879, Sigma) was dissolved in deionized water
as a 1 mM stock solution. Brefeldin A (203729, Calbiochem, La
Jolla, CA) was prepared as a 10 mg per mL stock in methanol.
Protein immunoblots Equivalent quantities of protein (50 mg/
lane), prepared from rapidly frozen keratome samples or lyzed
cultured human keratinocytes, were electrophoresed on denatur-
ing and reducing 12% polyacrylamide gels, and the fractionated
proteins were transferred to nitrocellulose. Membranes were
blocked with 1% bovine serum albumin for 1 h at room
temperature with gentle shaking, washed, and incubated for 1 h
at 251C with primary antibody. After being washed, the membrane
was incubated for 1 h at 251C with HRP-conjugated secondary
antibody (diluted 1:10,000). After being washed, the blots were
immersed in ECL western blotting detection reagent (Amersham
Pharmacia Biotech) for 1 min. Chemiluminescence was visualized
using Kodak X-OMAT AR imaging film (Eastman Kodak, Rochester,
NY). b-actin was detected using mouse anti-b-actin (1:1000)
followed by HRP-conjugated sheep anti-mouse IgG.
Cellular fractionation Near-confluent keratinocyte cultures
(6  50-cm2 dishes) were washed with phosphate-buffered saline
(PBS) and scraped into 1 mL of cell homogenization buffer (20 mM
Hepes, 2 mM ethylenediaminetetraacetic acid, 15.5 ng dithiothrei-
tol, 1 mM phenylmethylsulfonyl fluoride). Cells were disrupted by
sonication, centrifuged at 16110 g at 41C, and the supernatant was
saved as the soluble, cytosolic fraction. The cell pellet was
resuspended in 1 mL of cell homogenization buffer plus 5% Triton,
sonicated, and centrifuged at 16110 g at 41C. The resulting
supernatant was collected as the detergent-soluble, membrane
fraction. The remaining pellet was reconstituted in Laemmli sample
buffer. The fractioned proteins were electrophoresed on a 12%
acrylamide gel, and transferred to polyvinylidene difluoride
membrane. The blots were incubated overnight with polyclonal
rabbit anti-S100A11 (1:1000), washed, and incubated for 1 h with
HRP-conjugated donkey anti-rabbit IgG (1:10,000). The blots were
washed, after incubation with the secondary antibody, and
exposed to ECL detection reagents.
Tissue immunoﬂuorescence Keratomes, excised from normal
and psoriatic patients, were fixed for 12 h at 41C in 2%
paraformaldehyde, processed, sectioned, deparaffinized, etha-
nol-rehydrated, and rinsed with PBS. Nonspecific antibody binding
was blocked by incubating the sections for 30 min at 251C in 1.5%
rabbit serum (S-5000, Vector Laboratories) in PBS. Blocked
sections were incubated for 1 h at 251C with rabbit anti-S100A11
or mouse anti-CD1a diluted 1:100 in PBS. The sections were
then rinsed three times with PBS and incubated for 1 h at 251C
with Alexa Fluor 488-conjugated goat anti-rabbit IgG (1:1000), a
sensitive fluorescence detection reagent, or Cy3-conjugated
sheep anti-mouse IgG (1:1000). The slides were examined by a
laser scanning confocal microscope (Zeiss LSM510, Thornwood,
NY) with a 63  N.A. 1.4 oil immersion plan-apochromat objective.
Confocal images of green fluorescence were collected using 488-
nm excitation light from an argon/krypton laser, a 488-nm dichroic
mirror, and a 500- to 550-nm bandpass barrier filter. Images of red
fluorescence were collected using a 543-nm excitation light from
the HeNeI laser, a 543-nm dichroic mirror, and a 560-nm long pass
filter. The images were analyzed and processed using Adobe
Photoshop (version 7.0). The images are representative of at least
three separate experiments in which five fields were examined.
Immunoﬂuorescence of cultured cells Human keratinocytes
were plated onto 22  22-mm coverslips. After 24 h, cells were
treated with either 0.09 mM calcium chloride (low calcium) or
0.3 mM calcium chloride (high calcium) for 1 h. The cells were
then fixed with 4% paraformaldehyde for 1 h, permeabilized
with methanol for 10 min, and incubated with a primary antibody
cocktail containing rabbit anti-human S100A11 (1:1000) and goat
anti-human annexin I (1:500), mouse anti-b-tubulin (1:5000), mouse
anti-human BiP (1:250), or mouse anti-human GM130 (1:250). The
secondary antibody cocktail contained the appropriate combina-
tion of Alexa Fluor 488-conjugated anti-rabbit IgG (1:1000), Cy3-
conjugated sheep anti-mouse-IgG (1:500), Alexa Fluor 488-con-
jugated donkey anti-goat IgG (1:1000), or Cy3-conjugated sheep
anti-rabbit-IgG (1:500). The coverslips were then sealed onto
microscope slides using DABCO antifade reagent and sealant
(Molecular Probes). The slides were then examined by scanning
confocal microscopy, and the images were analyzed and pro-
cessed using Adobe Photoshop (version 7.0). The images are
representative of at least three separate experiments in which five
fields were examined.
Immunoprecipitation Near-confluent keratinocyte cultures (6  50-
cm2 dishes) were washed with PBS and scraped into 1 mL of
cell lysis buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 1 mM
ethylenediaminetetraacetic acid, 1 mM ethylene glycol bis tetra-
acetic acid, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM
b-glycerolphosphate, 1 mM Na3VO4, 1 mg per mL leupeptin, 1 mM
phenylmethylsulfonyl fluoride). Cells were disrupted by sonication
and centrifuged at 14,000  g at 41C, and the supernatant was
saved as whole-cell lysate. Protein concentrations were deter-
mined by Bradford assay.
Total protein (500 mg) was incubated with 2 mg of mouse anti-
b-tubulin antibody (sc5274, Santa Cruz Biotechnology) or 1 mg
of rabbit anti-S100A11 antibody for 3 h at 41C. Protein–antibody
complexes were then precipitated with protein (AþG)–agarose
(sc2003, Santa Cruz Biotechnology) for 1 h at 41C. Precipitates
were washed three times with lysis buffer and resuspended in 50
mL Laemmli sample buffer. The precipitated proteins were electro-
phoresed, in parallel, with 50 mg of whole cell lysate on a 12%
acrylamide gel and transferred to polyvinylidene difluoride mem-
brane. For b-tubulin detection, the blots were incubated overnight
with mouse anti-b-tubulin antibody (1:1000, T4026, Sigma),
washed, and incubated with HRP-conjugated donkey anti-mouse
IgG (1:10,000) for 1 h. For detection of S100A11, the blots
were incubated overnight with polyclonal rabbit anti-S100A11
(1:1000), washed, and incubated for 1 h with HRP-conjugated
donkey anti-rabbit IgG (1:10,000). All blots were washed after
incubation with the secondary antibody and exposed to ECL
detection reagents.
Microtubule disruption Human keratinocytes were plated onto
22  22-mm coverslips. After 24 h, cells were treated with or
without 1 mM vincristine for 2 h at 371C, to disrupt the microtubule
network, and then stimulated with either 0.09 or 0.3 mM calcium
chloride for 1 h. The cells were fixed with 4% paraformaldehyde for
1 h, permeabilized with methanol for 10 min, and incubated with a
primary antibody cocktail containing rabbit anti-human S100A11
(1:1000) and mouse anti-b-tubulin (1:5000). The secondary anti-
body cocktail contained Alexa Fluor 488-conjugated goat anti-
rabbit-IgG (1:1000) and Cy3-conjugated sheep anti-mouse-IgG
(1:500). The coverslips were sealed onto microscope slides and
examined by confocal microscopy.
This work utilized the facilities of the Skin Diseases Research Center of
Northeast Ohio (NIH AR39750) and the Ireland Cancer Center Confocal
Facility (NIH P30CA43703) and was supported by grants from the
National Institutes of Health (R.L.E.). The Developmental Biology
Training Program (NIH HD07104-25) provided A.M.B.’s salary.
DOI: 10.1046/j.0022-202X.2003.22105.x
Manuscript received February 14, 2003; revised August 20, 2003;
accepted for publication September 4, 2003
Address correspondence to: Richard L. Eckert, PhD, Department of
Physiology/Biophysics, Room E532, Case Western Reserve University
School of Medicine, 2109 Adelbert Road, Cleveland, OH 44106-4970.
S100 PROTEIN SIGNALING 37122 : 1 JANUARY 2004
References
Balasubramanian S, Agarwal C, Efimova T, et al: Thapsigargin suppresses
phorbol ester-dependent human involucrin promoter activity by suppres-
sing CCAAT-enhancer-binding protein alpha (C/EBPalpha) DNA binding.
Biochem J 350:791–796, 2000
Banchereau J, Paczesny S, Blanco P, et al: Dendritic cells: Controllers of the
immune system and a new promise for immunotherapy. Ann N Y Acad Sci
987:180–187, 2003
Boni R, Burg G, Doguoglu A, et al: Immunohistochemical localization of the Ca2þ
binding S100 proteins in normal human skin and melanocytic lesions. Br J
Dermatol 137:39–43, 1997
Boyce ST, Ham RG: Calcium-regulated differentiation of normal human epidermal
keratinocytes in chemically defined clonal culture and serum-free serial
culture. J Invest Dermatol 81:33s–40s, 1983
Broome AM, Ryan D, Eckert RL: S100 protein subcellular localization during
epidermal differentiation and psoriasis. J Histochem Cytochem 51:675–
685, 2003
Cumberbatch M, Dearman RJ, Griffiths CE, Kimber I: Langerhans cell migration.
Clin Exp Dermatol 25:413–418, 2000
Davey GE, Murmann P, Hoechli M, et al: Calcium-dependent translocation of
S100A11 requires tubulin filaments. Biochim Biophys Acta 1498:220–232,
2000
Deloulme JC, Assard N, Mbele GO, et al: S100A6 and S100A11 are specific
targets of the calcium- and zinc-binding S100B protein in vivo. J Biol
Chem 275:35302–35310, 2000
Donato R: Functional roles of S100 proteins, calcium-binding proteins of the EF-
hand type. Biochim Biophys Acta 1450:191–231, 1999
Donato R: S-100 proteins. Cell Calcium 7:123–145, 1986
Eckert RL, Crish JF, Robinson NA: The epidermal keratinocyte as a model for the
study of gene regulation and cell differentiation. Physiol Rev 77:397–424,
1997
Eckert RL, Yaffe MB, Crish JF, et al: Involucrin—Structure and role in envelope
assembly. J Invest Dermatol 100:613–617, 1993
Efimova T, LaCelle P, Welter JF, Eckert RL: Regulation of human involucrin
promoter activity by a protein kinase C, Ras, MEKK1, MEK3, p38/RK,
AP1 signal transduction pathway. J Biol Chem 273:24387–24395, 1998
Heizmann CW: Intracellular calcium-binding proteins. structure and possible
functions. J Cardiovasc Pharmacol 8 (Suppl 8):S7–S12, 1986
Heizmann CW, Cox JA: New perspectives on S100 proteins: A multi-functional
Ca(2þ )-, Zn(2þ )-, and Cu(2þ )-binding protein family. Biometals
11:383–397, 1998
Hennings H, Kruszewski FH, Yuspa SH, Tucker RW: Intracellular calcium
alterations in response to increased external calcium in normal and
neoplastic keratinocytes. Carcinogenesis 10:777–780, 1989
Kalinin AE, Kajava AV, Steinert PM: Epithelial barrier function: Assembly and
structural features of the cornified cell envelope. BioEssays 24:789–800,
2002
Mischke D, Korge BP, Marenholz I, et al: Genes encoding structural proteins of
epidermal cornification and S100 calcium-binding proteins form a gene
complex (‘epidermal differentiation complex’) on human chromosome
1q21. J Invest Dermatol 106:989–992, 1996
Moog-Lutz C, Bouillet P, Regnier CH, et al: Comparative expression of the
psoriasin (S100A7) and S100C genes in breast carcinoma and co-
localization to human chromosome 1q21-q22. Int J Cancer 63:297–303,
1995
Muesch A, Hartmann E, Rohde K, et al: A novel pathway for secretory proteins?
Trends Biochem Sci 15:86–88, 1990
Naka M, Qing ZX, Sasaki T, et al: Purification and characterization of a novel
calcium-binding protein, S100C, from porcine heart. Biochim Biophys
Acta 1223:348–353, 1994
Nestle FO, Nickoloff BJ: Dermal dendritic cells are important members of the skin
immune system. Adv Exp Med Biol 378:111–116, 1995
Pelham HR: Traffic through the Golgi apparatus. J Cell Biol 155:1099–1101, 2001
Phillips MA, Qin Q, Mehrpouyan M, Rice RH: Keratinocyte transglutaminase
membrane anchorage. Analysis of site-directed mutants. Biochemistry
32:11057–11063, 1993
Rammes A, Roth J, Goebeler M, et al: Myeloid-related protein (MRP) 8 and
MRP14, calcium-binding proteins of the S100 family, are secreted by
activated monocytes via a novel, tubulin-dependent pathway. J Biol
Chem 272:9496–9502, 1997
Reynolds NJ, Yi JY, Fisher GJ, et al: Down-regulation of Langerhans cell protein
kinase C-beta isoenzyme expression in inflammatory and hyperplastic
dermatoses. Br J Dermatol 133:157–167, 1995
Rice RH, Green H: Presence in human epidermal cells of a soluble protein
precursor of the cross-linked envelope: Activation of the cross-linking by
calcium ions. Cell 18:681–694, 1979
Rice RH, Mehrpouyan M, O’Callahan W, et al: Keratinocyte transglutaminase.
Differentiation marker and member of an extended family. Epithelial Cell
Biol 1:128–137, 1992
Robinson NA, Eckert RL: Identification of transglutaminase-reactive residues in
S100A11. J Biol Chem 273:2721–2728, 1998
Robinson NA, Lapic S, Welter JF, Eckert RL: S100A11, S100A10, annexin I,
desmosomal proteins, small proline-rich proteins, plasminogen activator
inhibitor-2, and involucrin are components of the cornified envelope of
cultured human epidermal keratinocytes. J Biol Chem 272:12035–12046,
1997
Roth J, Burwinkel F, van den Bos C, Goebler M, Vollmer E, Sorg C: MRP8 and
MRP14, S-100-like proteins associated with myeloid differentiation, are
translocated to plasma membrane and intermediate filaments in a
calcium-dependent manner. Blood 82:1875–1883, 1993
Ruse M, Lambert A, Robinson N, et al: S100A7, S100A10, and S100A11 are
transglutaminase substrates. Biochemistry 40:3167–3173, 2001
Sakaguchi M, Miyazaki M, Inoue Y, et al: Relationship between contact inhibition
and intranuclear S100C of normal human fibroblasts. J Cell Biol
149:1193–1206, 2000
Schafer BW, Heizmann CW: The S100 family of EF-hand calcium-binding
proteins: Functions and pathology. Trends Biochem Sci 21:134–140,
1996
Sciaky N, Presley J, Smith C, et al: Golgi tubule traffic and the effects of brefeldin
A visualized in living cells. J Cell Biol 139:1137–1155, 1997
Seemann J, Weber K, Gerke V: Structural requirements for annexin I-S100C
complex-formation. Biochem J 319:123–129, 1996
Sorci G, Agneletti AL, Bianchi R, Donato R: Association of S100B with
intermediate filaments and microtubules in glial cells. Biochim Biophys
Acta 1448:277–289, 1998
Steven AC, Bisher ME, Roop DR, Steinert PM: Biosynthetic pathways of filaggrin
and loricrin—Two major proteins expressed by terminally differentiated
epidermal keratinocytes. J Struct Biol 104:150–162, 1990
Teunissen MB: Dynamic nature and function of epidermal Langerhans cells in vivo
and in vitro: A review, with emphasis on human Langerhans cells.
Histochem J 24:697–716, 1992
Vincent MS, Gumperz JE, Brenner MB: Understanding the function of CD1-
restricted T cells. Nat Immunol 4:517–523, 2003
Vincent MS, Leslie DS, Gumperz JE, et al: CD1-dependent dendritic cell
instruction. Nat Immunol 3:1163–1168, 2002
Zhang T, Woods TL, Elder JT: Differential responses of S100A2 to oxidative stress
and increased intracellular calcium in normal, immortalized, and
malignant human keratinocytes. J Invest Dermatol 119:1196–1201, 2002
38 BROOME AND ECKERT THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
